The bacterial strains used in this study are listed in Table 1. CV026 is a mini-Tn5 mutant of the wild-type strain that lacks AHL synthase and can only produce violacein when the AHL signal molecules is supplied externally (McClean et al., 1997; Kothari et al., 2017). The E. coli strain pSB401 does not produce AHL and contains a plasmid based on LuxR of Vibrio fischeri and luxI promoter controlling luxCDABE expression (Winson et al., 1998). Transformation of DH5α/expI and SCC3065/expI was performed as described previously (Joshi et al., 2020). All strains were cultivated at 28°C in Luria-Bertani (LB) medium (Difco Laboratories, MI, United States). Strain pSB401 was cultivated at 37°C under continuous shaking at 150 rpm in a TU-400 incubator shaker (MRC, Holon, Israel). For the plant-inoculation assay, Murashige and Skoog minimal medium (MS; Duchefa, Haarlem, the Netherlands) was used. Solvents and chemicals were purchased from Sigma-Aldrich (Sigma-Aldrich), ciprofloxacin was purchased from Acros Organics. Phloretin was dissolved in DMSO to a concentration of 145 mM.

Strains used in this study.

Note: The content above has been extracted from a research article, so it may not display correctly.



Q&A
Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.



We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.